MedPath

Compare the effect of methimazole and hydroquinone cream in the treatment of melasma

Not Applicable
Conditions
Melasma.
Chloasma
Registration Number
IRCT2016041727445N1
Lead Sponsor
Vice chancellor for research, Shahid Beheshti University Skin Research Centerof Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
25
Inclusion Criteria

All the people in the age range of 50-20 years and all topical treatments for at least one month prior to study entry and are cut by a dermatologist examination with Wood's light examination (Wood) disease of epidermal melasma approved exclusion criteria and do not have;All people have informed consent to participate in the scheme.
Exclusion criteria:Pregnancy and lactation;There Type of melasma
3Use of any treatment for melasma in the last month;Use of oral contraceptives and hormone therapy and medication have any phototoxic;Past medical history of any thyroid disorders in patients

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficasy of methimazole 5%cream in severity of melasma with change in colore. Timepoint: Every 4 Weeks. Method of measurement: MASI Score.;Efficacy of hydroquinone 4%cream in severity of melasma with change in colore. Timepoint: Every 4 weeks. Method of measurement: MASI score.
Secondary Outcome Measures
NameTimeMethod
Side effects. Timepoint: Every four weeks. Method of measurement: Ask the patient.
© Copyright 2025. All Rights Reserved by MedPath